| Lung epithelial cells: therapeutically inducible effectors of antimicrobial defense MM Leiva-Juárez, JK Kolls, SE Evans Mucosal immunology 11 (1), 21-34, 2018 | 204 | 2018 |
| Lung epithelial cells are essential effectors of inducible resistance to pneumonia JO Cleaver, D You, DR Michaud, FAG Pruneda, MML Juarez, J Zhang, ... Mucosal immunology 7 (1), 78-88, 2014 | 82 | 2014 |
| MAGI1 as a link between endothelial activation and ER stress drives atherosclerosis J Abe, KA Ko, S Kotla, Y Wang, J Paez-Mayorga, IJ Shin, M Imanishi, ... JCI insight 4 (7), 2019 | 43 | 2019 |
| Inducible lung epithelial resistance requires multisource reactive oxygen species generation to protect against viral infections CT Kirkpatrick, Y Wang, MM Leiva Juarez, P Shivshankar, ... MBio 9 (3), 10.1128/mbio. 00696-18, 2018 | 39 | 2018 |
| Inducible epithelial resistance protects mice against leukemia-associated pneumonia MM Leiva-Juárez, HH Ware, VV Kulkarni, PA Zweidler-McKay, MJ Tuvim, ... Blood, The Journal of the American Society of Hematology 128 (7), 982-992, 2016 | 34 | 2016 |
| Fungal pneumonia in patients with hematologic malignancy and hematopoietic stem cell transplantation AY Young, MML Juarez, SE Evans Clinics in chest medicine 38 (3), 479-491, 2017 | 32 | 2017 |
| Systematic review of therapies for stable coronary artery disease in diabetic patients S Luthra, MM Leiva-Juárez, DP Taggart The Annals of Thoracic Surgery 100 (6), 2383-2397, 2015 | 32 | 2015 |
| Systematic review of randomized controlled trials of endothelin receptor antagonists for pulmonary arterial hypertension M Kuntz, MM Leiva-Juarez, S Luthra Lung 194, 723-732, 2016 | 30 | 2016 |
| Combined aerosolized Toll-like receptor ligands are an effective therapeutic agent against influenza pneumonia when co-administered with oseltamivir MM Leiva-Juarez, CT Kirkpatrick, BE Gilbert, B Scott, MJ Tuvim, BF Dickey, ... European journal of pharmacology 818, 191-197, 2018 | 26 | 2018 |
| Inducible lung epithelial resistance requires multisource reactive oxygen species generation to protect against bacterial infections HH Ware, VV Kulkarni, Y Wang, J Pantaleón García, M Leiva Juarez, ... PLoS One 14 (2), e0208216, 2019 | 25 | 2019 |
| Aspiration of conjugated bile acids predicts adverse lung transplant outcomes and correlates with airway lipid and cytokine dysregulation A Urso, MM Leiva-Juárez, DF Briganti, B Aramini, L Benvenuto, J Costa, ... The Journal of Heart and Lung Transplantation 40 (9), 998-1008, 2021 | 20 | 2021 |
| Extended post ex-vivo lung perfusion cold preservation predicts primary graft dysfunction and mortality: Results from a multicentric study MM Leiva-Juárez, A Urso, EA Tomás, DJ Lederer, P Sanchez, B Griffith, ... The Journal of Heart and Lung Transplantation 39 (9), 954-961, 2020 | 18 | 2020 |
| Percutaneous intervention before coronary artery bypass surgery does not unfavorably impact survival: a single-center propensity-matched analysis S Luthra, MML Juárez, E Senanayake, H Luckraz, JS Billing, J Cotton, ... The Annals of thoracic surgery 102 (6), 1911-1918, 2016 | 15 | 2016 |
| Is resident training safe in cardiac surgery? S Luthra, MM Leiva-Juarez, A Ismail, GM Tsang, CW Barlow, T Velissaris, ... The Annals of Thoracic Surgery 110 (4), 1404-1411, 2020 | 14 | 2020 |
| Extracorporeal life support as a bridge to pulmonary retransplantation: prognostic factors for survival in a multicentre cohort analysis I Inci, JP Ehrsam, D Van Raemdonck, LJ Ceulemans, T Krüger, ... European Journal of Cardio-Thoracic Surgery 61 (2), 405-412, 2022 | 10 | 2022 |
| Risk factors and outcomes for gastroparesis after lung transplantation JW Blackett, L Benvenuto, MM Leiva-Juarez, F D’Ovidio, S Arcasoy, ... Digestive Diseases and Sciences, 1-10, 2022 | 9 | 2022 |
| Identification of lung transplant recipients with a survival benefit after fundoplication MM Leiva-Juarez, L Benvenuto, J Costa, JW Blackett, M Aversa, ... The Annals of Thoracic Surgery 113 (6), 1801-1810, 2022 | 8 | 2022 |
| Surgical vs transfemoral aortic valve replacement in low‐risk patients: an updated meta‐analysis of trial and registry data S Luthra, MM Leiva‐Juárez, SK Ohri Journal of Cardiac Surgery 35 (9), 2264-2274, 2020 | 8 | 2020 |
| Does a third arterial conduit to the right coronary circulation improve survival? S Luthra, MM Leiva-Juárez, M Matuszewski, IS Morgan, JS Billing The Journal of Thoracic and Cardiovascular Surgery 155 (3), 855-860. e2, 2018 | 7 | 2018 |
| Lung epithelial cells: therapeutically inducible effectors of antimicrobial defense. Mucosal Immunol 11: 21–34 MM Leiva-Juarez, JK Kolls, SE Evans | 7 | 2017 |
